Evidence map›Paper›PMID 35032242›Full record

ArticleCancer causes & control : CCC2022

Racial/ethnic disparities in patient experiences with care and Gleason score at diagnosis of prostate cancer: a SEER-CAHPS study.

Stephanie Navarro, Xiaohui Hu, Aaron Mejia, Carol Y Ochoa, Trevor A Pickering, Leslie Ballas, Albert J Farias

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stephanie NavarroDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, 2001 N. Soto Street, Suite 318B, Los Angeles, CA, 90032, USA.
Xiaohui HuDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, 2001 N. Soto Street, Suite 318B, Los Angeles, CA, 90032, USA.
Aaron MejiaDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, 2001 N. Soto Street, Suite 318B, Los Angeles, CA, 90032, USA.
Carol Y OchoaDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, 2001 N. Soto Street, Suite 318B, Los Angeles, CA, 90032, USA.
Trevor A PickeringDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, 2001 N. Soto Street, Suite 318B, Los Angeles, CA, 90032, USA.
Leslie BallasUSC Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA.
Albert J FariasDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, 2001 N. Soto Street, Suite 318B, Los Angeles, CA, 90032, USA. albertfa@usc.edu.ORCID http://orcid.org/0000-0002-6463-7831
University of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine whether racial/ethnic differences in patient experiences with care, potentially leading to underutilization of necessary care, are associated with disparities in Gleason score at diagnosis.

methodsWe used the SEER-CAHPS linked dataset to identify Medicare beneficiaries who completed a Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey prior to diagnosis of prostate cancer. Independent variables included aspects of patient experiences with care captured by CAHPS surveys. We conducted survey weighted multivariable multinomial logistic regression analyses, stratified by patient race/ethnicity, to estimate associations of CAHPS measures with Gleason score at diagnosis.

resultsOf the 4,245 patients with prostate cancer, most were non-Hispanic white (NHW) (77.6%), followed by non-Hispanic black (NHB) (8.4%), Hispanic (8.4%), and Asian (5.6%). Excellent experience with getting needed prescription drugs was associated with lower odds of Gleason scores of 7 and 8-10 in NHBs (7: OR = 0.19, 95% CI = 0.05-0.67; 8-10: OR = 0.04, 95% CI = 0.01-0.2) and lower odds of 8-10 in NHWs (OR = 0.61, 95% CI = 0.40-0.93). For NHBs, excellent primary physician ratings were associated with greater odds of a Gleason score of 8-10 (OR = 13.28, 95% CI = 1.53-115.21).

conclusionPatient experiences with access to care and physician relationships may influence Gleason score in different ways for patients of different racial/ethnic groups. More research, including large observational studies with greater proportions of racial/ethnic minority patients, is necessary to understand these relationships and target interventions to overcome disparities and improve patient outcomes.

Indexed as

EthnicityProstatic NeoplasmsAgedHealthcare DisparitiesHumansMaleMedicareMinority GroupsNeoplasm GradingPatient Outcome AssessmentUnited StatesGleason scoreHealth care disparitiesPatient experienceProstate cancerProstate cancer racial/ethnic disparitiesSEER-CAHPS

Identifiers

PMID35032242
OpenAlexW4205567381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.